Allergic Rhinitis Drugs Market Report 2023-2033


Forecasts by Treatment (Antihistamines, Immunotherapy (SCIT, SLIT), Corticosteroids, Decongestants, Others), by Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), by Route of Administration (Oral, Nasal, Intraocular, Intravenous), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis.

New York, Feb. 07, 2023 (GLOBE NEWSWIRE) -- announces the release of the report "Allergic Rhinitis Drugs Market Report 2023-2033" -

The Allergic Rhinitis Drugs Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advent of Innovative Intranasal Therapies for Treatment of Allergic Rhinitis

Intranasal therapies are gaining acceptance owing to their better safety and efficacy. This route of administration is also recommended by physicians and allergists since they do not have any systemic side-effects and their adequate concentrations can be achieved at receptor sides in nasal mucosa. Their adverse effects are limited to dryness, sneezing and stinging of nasal mucosa. Several companies are developing innovative intranasal drugs owing to their inherent advantages over other routes of administration. For instance, ClorNasal™ developed by Dr. Ferrer BioPharma is recognized as the best intranasal pharmacological formulation in the world. It is used in the treatment of several ailments including allergic rhinitis, Respiratory Syncytial Virus (RSV) Infection and COVID-19. Similarly, Altamira Therapeutics Ltd. Developed the nasal spray Bentrino. It prevents the onset of allergic symptoms by airborne allergens such as dust mites, and pollens.

Similarity of Symptoms With Other Diseases

Allergic rhinitis is an infection caused due to allergic reaction of immune system to an allergen. Some of the most common symptoms of allergic rhinitis include stuffy nose, watery eyes, itchy mouth, sneezing, post-nasal drip, sore throat, facial pain or pressure, partial loss of hearing, smell, and taste, and fatigue among others. The symptoms are very similar to cold and cough which might be caused by virus and not by any of the agents that cause allergies. The allergies can also trigger other conditions such as asthma, sinusitis, otitis media or eczema if not treatment well in time. Selection of the right drug candidate remains a major problem in the absence of accurate diagnosis. Administration of immunotherapy or allergy shots may have serious side effects such as hives and rash. It may sometimes have dangerous side effects such as anaphylaxis which may require years of treatment.

Adverse Effects of Drugs Used in Allergic Rhinitis Treatment

Allergic medications are mostly used over a long period of time to keep the lifestyle unaffected by different types of allergens in the environment. Antihistamines are the most widely used drug type for treatment of allergic infections. Some of the short-term side-effects of antihistamines include constipation, urinary retention, dry mouth, enhanced appetite, and worsen narrow-angle glaucoma. Several side-effects of nasal decongestants include high blood pressure, irritability, headache, and sleeplessness. Topical corticosteroids cause absorption of the drug into the systemic circulation which has potential to cause disturbance to the normal hormonal levels in the body. Corticosteroid ocular solutions can cause glaucoma, cataract and other eye infections. Intranasal corticosteroids can irritate nasal mucosa and also affect the cell lining of mouth and throat make them dry and soar. Oral corticosteroids are associated with side-effects such as osteoporosis, stomach ulceration, hyperglycaemia, increased blood pressure and muscle weakness.

What Questions Should You Ask before Buying a Market Research Report?

• How is the Allergic Rhinitis Drugs Market evolving?

• What is driving and restraining the Allergic Rhinitis Drugs Market?

• How will each Allergic Rhinitis Drugs submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?

• How will the market shares for each Allergic Rhinitis Drugs submarket develop from 2023 to 2033?

• What will be the main driver for the overall market from 2023 to 2033?

• Will leading Allergic Rhinitis Drugs Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?

• Who are the leading players and what are their prospects over the forecast period?

• What are the Allergic Rhinitis Drugs development projects for these leading companies?

• How will the industry evolve during the period between 2023 and 2033? What are the implications of Allergic Rhinitis Drugs development projects taking place now and over the next 10 years?

• Is there a greater need for product commercialisation to further scale the Allergic Rhinitis Drugs Market?

• Where is the Allergic Rhinitis Drugs Market heading and how can you ensure you are at the forefront of the market?

• What are the best investment options for new product and service lines?

• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Allergic Rhinitis Drugs Market today, and over the next 10 years:

• Our 269-page report provides 105 tables and 173 charts/graphs exclusively to you.

• The report highlights key lucrative areas in the industry so you can target them – NOW.

• It contains in-depth analysis of global, regional and national sales and growth.

• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Allergic Rhinitis Drugs Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.

• You will find original analyses, with business outlooks and developments.

• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising prices of allergic rhinitis drugs and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Treatment Type

• Antihistamines

• Immunotherapy

- Subcutaneous Immunotherapy (SCIT)

- Sublingual Immunotherapy (SLIT)

• Corticosteroids

• Decongestants

• Others

Disease Type

• Seasonal Allergic Rhinitis

• Perennial Allergic Rhinitis

• Occupational Allergic Rhinitis

Route of Administration

• Oral

• Nasal

• Intraocular

• Intravenous

Distribution Channel

• Retail Pharmacies

• Hospital Pharmacies

• Online channels

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America

• U.S.

• Canada


• Germany

• UK

• France

• Spain

• Italy

• Russia

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• Australia

• South Korea

• Rest of Asia Pacific

Latin America

• Brazil

• Mexico

• Rest of Latin America



• South Africa

• Rest of MEA

The report also includes profiles and for some of the leading companies in the Allergic Rhinitis Drugs Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

• Alcon

• AstraZeneca

• Bayer AG

• Dr Reddy’s Laboratories

• GlaxoSmithKline PLC

• Johnson and Johnson

• Merck and Co

• Sanofi S.A.

• Sun Pharmaceuticals

• Teva Pharmaceutical Industries Ltd

Overall world revenue for Allergic Rhinitis Drugs Market, 2023 to 2033 in terms of value the market will surpass US$12,410 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Allergic Rhinitis Drugs Market, 2023 to 2033 report help you?

In summary, our 260+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Allergic Rhinitis Drugs Market, 2023 to 2033 Market, with forecasts for Type of Treatment, Disease, Route of Administration and Distribution channel at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Allergic Rhinitis Drugs Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Allergic Rhinitis Drugs Market, 2023 to 2033.

Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001